Health Insurance Companies Related Topics 
Perficient: Drug Development
JANUARY 25, 2024
To recap: Part 1 of the series focused on providers This part, Part 2, focuses on payers (insurance companies) Part 3 (by Marlana Voerster ) will focus on medical-device organizations First off: the bad news in trust for payers Gallup’s polling data among U.S.
The Pharma Data
NOVEMBER 16, 2020
Yang pointed out that “the fact that it’s generic is a double-edged sword, because no big pharma company is willing to invest a lot of money in developing and marketing a polypill. It may require either health insurance companies or governments or charitable organizations to develop polypills.”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
OCTOBER 27, 2020
Under the Affordable Care Act, health insurance companies are required to cover the full cost of any screening test recommended by the U.S. Computer models suggest that about 25 colon cancer deaths are prevented for every 1,000 Americans between 50 and 75 who are screened, Barry said. Preventive Services Task Force (USPSTF).
Conversations in Drug Development Trends
DECEMBER 12, 2022
While the Genetic Information Nondiscrimination Act (GINA) prohibits discrimination by health insurance companies and employers based on a genetic test result, GINA does not apply to life, long-term care, or disability insurance.
Perficient: Drug Development
JANUARY 20, 2025
Your health insurance organization has a trust and understanding problem By and large, healthcare consumers dont trust health insurance companies. We know this, and the data backs us up. But where does this lack of trust come from?
The Pharma Data
NOVEMBER 10, 2020
Prior to the passage of the ACA (also known as Obamacare) in March of 2010, health insurance companies routinely denied new coverage — or sometimes charged exorbitant premiums — to people with a prior history of illness.
Expert insights. Personalized for you.
52 
Let's personalize your content